SGH
Sivik Global Healthcare Portfolio holdings
AUM
$224M
This Quarter Return
+16.66%
1 Year Return
+5.3%
3 Year Return
+45.33%
5 Year Return
+103.79%
10 Year Return
+430.94%
AUM
$213M
AUM Growth
+$213M
(+18%)
Cap. Flow
+$5.71M
Cap. Flow
% of AUM
2.69%
Top 10 Holdings %
Top 10 Hldgs %
40.38%
Holding
46
New
5
Increased
12
Reduced
13
Closed
7
Top Buys
| 1 |
SPDR S&P Biotech ETF
XBI
|
$13.6M |
| 2 |
Vertex Pharmaceuticals
VRTX
|
$4.33M |
| 3 |
Icon
ICLR
|
$2.91M |
| 4 |
Globus Medical
GMED
|
$2.8M |
| 5 |
Moderna
MRNA
|
$2.34M |
Top Sells
| 1 |
Johnson & Johnson
JNJ
|
$3.98M |
| 2 |
Centene
CNC
|
$3.89M |
| 3 |
Medtronic
MDT
|
$2.42M |
| 4 |
Thermo Fisher Scientific
TMO
|
$2.2M |
| 5 |
UnitedHealth
UNH
|
$2.12M |
Sector Composition
| 1 | Healthcare | 93.17% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
26
Vertex Pharmaceuticals
VRTX
$100B
| $4.33M | 2.04% |
+15,000
| New | +$4.33M |
|
|
27
UnitedHealth
UNH
$281B
| $4.24M | 1.99% |
8,000
-4,000
| -33% | -$2.12M |
|
28
Elevance Health
ELV
$71.8B
| $4.1M | 1.93% |
8,000
-3,000
| -27% | -$1.54M |
|
29
Option Care Health
OPCH
$4.65B
| $3.91M | 1.84% |
130,000
+20,000
| +18% | +$602K |
|
30
IQVIA
IQV
$32.4B
| $3.07M | 1.45% |
15,000
+5,000
| +50% | +$1.02M |
|
|
31
Icon
ICLR
$13.8B
| $2.91M | 1.37% |
+15,000
| New | +$2.91M |
|
32
Revvity
RVTY
$10.5B
| $2.8M | 1.32% |
20,000
-5,000
| -20% | -$701K |
|
|
33
Globus Medical
GMED
$8.27B
| $2.8M | 1.32% |
+37,745
| New | +$2.8M |
|
34
Biogen
BIIB
$19.4B
| $2.77M | 1.3% |
10,000
| – | – |
|
|
35
Johnson & Johnson
JNJ
$427B
| $2.65M | 1.25% |
15,000
-22,500
| -60% | -$3.98M |
|
36
Select Medical
SEM
$1.61B
| $2.48M | 1.17% |
100,000
-30,000
| -23% | -$745K |
|
|
37
Moderna
MRNA
$9.37B
| $2.34M | 1.1% |
+13,000
| New | +$2.34M |
|
38
BioNTech
BNTX
$24B
| $1.95M | 0.92% |
+13,000
| New | +$1.95M |
|
|
SGEN
39
DELISTED
Seagen Inc. Common Stock
SGEN
| $1.67M | 0.79% |
13,000
+3,000
| +30% | +$386K |
|
|
AMED
40
DELISTED
Amedisys
AMED
| – | – |
-17,500
| Closed | -$1.69M |
|
41
Avantor
AVTR
$9.18B
| – | – |
-100,000
| Closed | -$1.96M |
|
|
42
Centene
CNC
$14.3B
| – | – |
-50,000
| Closed | -$3.89M |
|
43
Enhabit
EHAB
$399M
| – | – |
-62,594
| Closed | -$879K |
|
44
Incyte
INCY
$16.5B
| – | – |
-18,755
| Closed | -$1.25M |
|
|
45
Medtronic
MDT
$119B
| – | – |
-30,000
| Closed | -$2.42M |
|
46
Royalty Pharma
RPRX
$15.6B
| – | – |
-45,008
| Closed | -$1.81M |
|